{"organizations": [], "uuid": "b749d2952949114e022d46f6db218e7b2eb7a45a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180123.html", "section_title": "Archive News &amp; Video for Tuesday, 23 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-biomerieux-fy-sales-rise-102-pct-t/brief-biomerieux-fy-sales-rise-10-2-pct-to-eur-2288-million-idUSFWN1PH185", "country": "US", "domain_rank": 408, "title": "BRIEF-Biomerieux FY ‍Sales Rise 10.2 Pct To EUR 2,288 Million", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.032, "site_type": "news", "published": "2018-01-23T14:13:00.000+02:00", "replies_count": 0, "uuid": "b749d2952949114e022d46f6db218e7b2eb7a45a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-biomerieux-fy-sales-rise-102-pct-t/brief-biomerieux-fy-sales-rise-10-2-pct-to-eur-2288-million-idUSFWN1PH185", "ord_in_thread": 0, "title": "BRIEF-Biomerieux FY ‍Sales Rise 10.2 Pct To EUR 2,288 Million", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "biomérieux", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 23 (Reuters) - BIOMERIEUX SA:\n* ‍SALES MOMENTUM IN 2017 WITH 10.2% GROWTH IN SALES TO EUR 2,288 MILLION IN SALES​\n* NET DEBT AMOUNTED TO EUR 156 MILLION AT DECEMBER 31, 2017, VERSUS EUR 275 MILLION AT DECEMBER 31, 2016.\n* Q4 2017 SALES FOR BIOMÉRIEUX ROSE 8.9% ON Q4 2016​ * EXPECTS CONTRIBUTIVE OPERATING INCOME BEFORE NON-RECURRING ITEMS TO BE IN LINE WITH ITS PREVIOUS TARGET\n* CHANGE IN FEDERAL INCOME TAX RATE WILL IMPACT FISCAL YEAR 2017 WITH A NON-RECURRING AND NON-CASH BENEFIT OF AROUND EUR 30 MLN\n* BIOMÉRIEUX ESTIMATES EFFECTIVE TAX RATE IN 2018 AT BETWEEN 24% AND 26% Source text for Eikon: Further company coverage: (Gdynia Newsroom:)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-23T14:13:00.000+02:00", "crawled": "2018-01-24T15:35:34.000+02:00", "highlightTitle": ""}